Thyrocare Technologies Ltd Financials
Company Logo

Thyrocare Technologies Ltd Financial Statement

Thyrocare Technologies Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars
Jun 2024
Revenue146.80
Operating Expense101.28
Net Profit25.15
Net Profit Margin17.13
Earning Per Share4.75
EBIDTA45.54
Effective Tax Rate21.99

Thyrocare Technologies Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Total Revenue Annual524.02
Operating Expenses Annual390.14
Operating Profit Annual141.06
Interest Annual3.73
Depreciation31.55
Net Profit Annual71.14
Tax Annual27.08

Thyrocare Technologies Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Cash Flow at the Beginning12.37
Cash Flow from Operations155.19
Cash Flow from Investing-80.29
Cash Flow from Financing-83.71
Cash Flow at the End3.56

Thyrocare Technologies Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
PBDIT Margin (%)27.14
PBIT Margin (%)19.67
PBT Margin (%)15.64
Net PROFIT Margin (%)13.58
Return On Networth / Equity (%)13.75
Return On Networth /Employed (%)18.63
Return On Assets (%)12.90
Total Debt / Equity (X)0.06
Asset Turnover Ratio (%)0.95

Thyrocare Technologies Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Fixed Assets Annual158.29
Total Current Assets Annual245.65
Non Current Assets Annual374.62
Total Shareholders Funds Annual513.81
Total Assets Annual620.27

Thyrocare Technologies Ltd Earning Calls

EPS (INR)

Expected

4.56

Reported

4.52

Surprise

-0.88%

Mar 2024

EPS beaten by -0.88%

Dec 2023

EPS beaten by 5.36%

Sep 2023

EPS beaten by -4.14%

Get Your FAQs Right

As of Oct 13, 2024, Thyrocare Technologies Ltd has a market capitalization of 3,135.86 Cr. Value Research classifies it as a Mid-Cap company.
Yes, Thyrocare Technologies Ltd is debt-free with a debt-to-equity ratio of 0.08.
In FY 2023 , Thyrocare Technologies Ltd recorded a total revenue of approximately 524.02 Cr marking a significant milestone in the company's financial performance.
Thyrocare Technologies Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately -0.1% and -0.0% annually, respectively..
Thyrocare Technologies Ltd's current PE ratio is 44.08.
Thyrocare Technologies Ltd's ROCE averaged 24.1% from the FY ending March 2022 to 2024, with a median of 18.3%. It peaked at 38.7% in March 2022, reflecting strong capital efficiency over the period..
Thyrocare Technologies Ltd's latest EBIT is Rs. 101.95 Cr, surpassing the average EBIT of Rs. 131.68 Cr over the 5 years..